Medical research
Enhancing hypoxia-activated prodrug anticancer therapy
Hypoxia-activated prodrugs (HAPs) have the potential to activate specifically in hypoxic tumors and eliminate tumor cells, which has brought new opportunities for safe and effective anticancer therapy. However, their therapeutic ...
Apr 3, 2024
0
0
